38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background & Aims

          In fecal samples from patients with chronic constipation, the microbiota differs from that of healthy subjects. However, the profiles of fecal microbiota only partially replicate those of the mucosal microbiota. It is not clear whether these differences are caused by variations in diet or colonic transit, or are associated with methane production (measured by breath tests). We compared the colonic mucosal and fecal microbiota in patients with chronic constipation and in healthy subjects to investigate the relationships between microbiota and other parameters.

          Methods

          Sigmoid colonic mucosal and fecal microbiota samples were collected from 25 healthy women (controls) and 25 women with chronic constipation and evaluated by 16S ribosomal RNA gene sequencing (average of 49,186 reads/sample). We assessed associations between microbiota (overall composition and operational taxonomic units) and demographic variables, diet, constipation status, colonic transit, and methane production (measured in breath samples after oral lactulose intake).

          Results

          Fourteen patients with chronic constipation had slow colonic transit. The profile of the colonic mucosal microbiota differed between constipated patients and controls ( P<.05). The overall composition of the colonic mucosal microbiota was associated with constipation, independent of colonic transit ( P<.05) and discriminated between patients with constipation and controls with 94% accuracy. Genera from Bacteroidetes were more abundant in the colonic mucosal microbiota of patients with constipation. The profile of the fecal microbiota was associated with colonic transit before adjusting for constipation, age, body mass index, and diet; genera from Firmicutes ( Faecalibacterium, Lactococcus, and Roseburia) correlated with faster colonic transit. Methane production was associated with the composition of the fecal microbiota, but not with constipation or colonic transit.

          Conclusions

          After adjusting for diet and colonic transit, the profile of the microbiota in the colonic mucosa could discriminate patients with constipation from healthy individuals. The profile of the fecal microbiota was associated with colonic transit and methane production (measured in breath), but not constipation.

          Related collections

          Author and article information

          Journal
          0374630
          3841
          Gastroenterology
          Gastroenterology
          Gastroenterology
          0016-5085
          1528-0012
          16 October 2015
          13 October 2015
          February 2016
          01 February 2017
          : 150
          : 2
          : 367-379.e1
          Affiliations
          [1 ]Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905 USA
          [2 ]Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905 USA
          [3 ]Clinical Research and Trials Unit, Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, 55905 USA
          [4 ]Departments of Animal Sciences and Pathobiology, Division of Nutritional Sciences, University of Illinois, Urbana-Champaign, IL 61801 USA
          [5 ]Center for Individualized Medicine, Mayo Clinic, Rochester, MN, 55905 USA
          Author notes
          Corresponding Author and Contact for Reprint Requests: Adil E Bharucha, M.B.B.S., M.D., Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905 USA, Phone: 507-284-2687, Fax: 507-538-5820, bharucha.adil@ 123456mayo.edu
          Article
          PMC4727996 PMC4727996 4727996 nihpa730026
          10.1053/j.gastro.2015.10.005
          4727996
          26460205
          af3311a6-01b3-4d53-b230-28f296bc60a1
          History
          Categories
          Article

          irritable bowel syndrome,microbiome
          irritable bowel syndrome, microbiome

          Comments

          Comment on this article